CoChat

Is Ketamine Efficacious for Rapid Treatment of Acute Suicidal Ideation in an Emergency Setting? Lessons Learned from A Pilot Randomized Controlled Trial

Open access
Barzkar, Maryam, Alavi, Kaveh, Malakouti, Kazem, Khajeh-Azad, Mohamad-Amin, Barzkar, Farzaneh, Jalali-Nadoushan, Amirhossein, Lahiji, Mohammad Niakan · 2024 · BMC Research Notes

Preprint — published as 10.1186/s13104-024-07029-7 · Paper page

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Background Ketamine has emerged as a promising agent for the rapid reduction of suicidal thoughts. However, its efficacy across a broader spectrum of psychiatric disorders remains underexplored.Objective This study aimed to evaluate the efficacy of a single infusion of ketamine in inducing rapid remission of severe suicidal ideation, compared to Midazolam, in a population with acute suicidal thoughts.Methods In a double-blind randomized controlled trial conducted in Tehran, Iran, from January to July 2022 (IRCT20220118053756N1), 36 inpatients with acute severe suicidal ideation were enrolled. Participants were randomly assigned to receive either a single dose of ketamine (0.5 mg/kg) or Midazolam (0.02 mg/kg). Suicidality was assessed using the Beck Scale for Suicide Ideation (BSSI) and the Suicide-Visual Analog Scale (S-VAS) before the intervention and at 12 and 24 hours post-administration.Results At baseline, the Midazolam group exhibited significantly higher BSSI scores and a higher rate of borderline personality disorder than the Ketamine group. Mean BSSI and S-VAS scores at 12 and 24 hours after the treatment in both groups. Despite these observations, no statistically significant differences were found between the groups in terms of BSSI and S-VAS scores.Conclusions The findings suggest that ketamine may reduce suicidal ideation, but its efficacy varies by psychiatric diagnosis. The groups were not significantly different in the main study outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.21203/rs.3.rs-4718815/v1

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The CONSORT diagram demonstartes the participants’ flow during the trial. All patients received the intended treatment and none of them left the study
Fig. 1 The CONSORT diagram demonstartes the participants’ flow during the trial. All patients received the intended treatment and none of them left the studyCC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 16

  1. Kastrup MC. Health Coverage and Mental Illness: The Ongoing Issue of Mental Health Gap (mhGAP). Indian J Social Psychiatry. 2016;32(3):251–3. · DOI
  2. Weber AN, Michail M, Thompson A, Fiedorowicz JG. Psychiatric emergencies: assessing and managing suicidal ideation. Med Clin. 2017;101(3):553–71.
  3. Caddy C, Giaroli G, White TP, Shergill SS, Tracy DK. Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy. Therapeutic Adv Psychopharmacol. 2014;4(2):75–99. · DOI · Paper page
  4. Ballard ED, Fields J, Farmer CA, Zarate CA Jr. Clinical trials for rapid changes in suicidal ideation: Lessons from ketamine. Suicide Life-Threatening Behav. 2021;51(1):27–35. · DOI · Paper page
  5. Siegel AN, Di Vincenzo JD, Brietzke E, Gill H, Rodrigues NB, Lui LM, et al. Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic review. J Psychiatr Res. 2021;137:426–36. · DOI · Paper page
  6. Wilkinson ST, Ballard ED, Bloch MH, Mathew SJ, Murrough JW, Feder A, et al. The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis. Am J Psychiatry. 2018;175(2):150–8. · DOI · Paper page
  7. Witt K, Potts J, Hubers A, Grunebaum MF, Murrough JW, Loo C, et al. Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials. Australian New Z J Psychiatry. 2019;54(1):29–45. · DOI · Paper page
  8. Ahmadpanah M, Sheikhbabaei M, Haghighi M, Roham F, Jahangard L, Akhondi A, et al. Validity and test-retest reliability of the Persian version of the Montgomery-Asberg Depression Rating Scale. Neuropsychiatr Dis Treat. 2016;12:603–7.
  9. Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight? Am J Psychiatry. 2004;161(12):2163–77. · DOI · Paper page
  10. Esfahani M, Hashemi Y, Alavi K. Psychometric assessment of Beck scale for suicidal ideation (BSSI) in general population in Tehran. MJIRI. 2015;29(1):862–71.
  11. Abbar M, Demattei C, El-Hage W, Llorca P-M, Samalin L, Demaricourt P et al. Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial. BMJ. 2022;376.
  12. Grunebaum MF, Galfalvy HC, Choo TH, Keilp JG, Moitra VK, Parris MS, et al. Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial. Am J Psychiatry. 2018;175(4):327–35. · DOI · Paper page
  13. Domany Y, Shelton RC, McCullumsmith CB. Ketamine for acute suicidal ideation. An emergency department intervention: A randomized, double-blind, placebo‐controlled, proof‐of‐concept trial. Depress Anxiety. 2020;37(3):224–33. · DOI · Paper page
  14. Chen KS, Dwivedi Y, Shelton RC. The effect of IV ketamine in patients with major depressive disorder and elevated features of borderline personality disorder. J Affect Disord. 2022;315:13–6. · DOI
  15. LINKS PS, Boggild A, Sarin N. Modeling the relationship between affective lability, impulsivity, and suicidal behavior in patients with borderline personality disorder. J Psychiatric Practice®. 2000;6(5):247–55. · DOI
  16. Rizk MM, Choo T-H, Galfalvy H, Biggs E, Brodsky BS, Oquendo MA, et al. Variability in suicidal ideation is associated with affective instability in suicide attempters with borderline personality disorder. Psychiatry. 2019;82(2):173–8. · DOI · Paper page

Metadata

Authors
Barzkar, M., Alavi, K., Malakouti, K., Khajeh-Azad, M.-A., Barzkar, F., Jalali-Nadoushan, A., & Lahiji, M. N.
Affiliations
  • Iran University of Medical Sciences (IR)
  • Mental Health Research Center, Psychosocial Health Research Institute, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran,
Venue
BMC Research Notes
Published
2024-08-11
Volume
18
Issue
1
Pages
65-65
ISSN
1756-0500 (ISSN-L)
OpenAlex
W4407423713
Cited by
1
References
1
Citations by year
2026: 1
FWCI
1.18
Type
journal article
Language
en
Open access
Locations
  • BMC Research Notes (publishedVersion, cc-by-nc-nd)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords
ketamine, suicidal ideation, midazolam, rapid remission, borderline personality disorder, suicide risk, single-dose infusion, Beck Scale for Suicide Ideation
MeSH terms
Adult, Double-Blind Method, Emergency Service, Hospital, Female, Humans, Iran, Ketamine, Male, Midazolam, Middle Aged, Pilot Projects, Treatment Outcome, Young Adult, Suicidal Ideation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Is Ketamine Efficacious for Rapid Treatment of Acute Suicidal Ideation in an Emergency Setting? Lessons Learned from A Pilot Randomized Controlled Trial. https://app.cochat.ai/papers/10.21203/rs.3.rs-4718815/v1
The paper
Barzkar, M., Alavi, K., Malakouti, K., Khajeh-Azad, M.-A., Barzkar, F., Jalali-Nadoushan, A., & Lahiji, M. N. (2024). Is Ketamine Efficacious for Rapid Treatment of Acute Suicidal Ideation in an Emergency Setting? Lessons Learned from A Pilot Randomized Controlled Trial. BMC Research Notes. https://doi.org/10.21203/rs.3.rs-4718815/v1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.